Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Critical Care
Published in: Critical Care 5/2000

01-12-2000 | Meeting abstract

An audit of blood and blood product use in the Cardiac Intensive Care Unit (CICU)

Authors: L Bell, L Anderson, A Macfie

Published in: Critical Care | Special Issue 5/2000

Login to get access

Excerpt

Cardiac surgical patients use 10-20% of the nation's blood products [1]. Recent work [2] suggests a lower acceptable haematocrit for cardiac surgical patients during the perioperative period. This, and a change in our unit's policy to increase the availability of platelets and clotting factors (`crash packs') for these patients, prompted us to conduct this audit in order to determine whether our therapy was appropriately targeted. …
Literature
1.
Shore-Lesserson L, Manspeizer HE, De Perio M, et al.: Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg 1999, 88: 312-319. 10.1097/00000539-199902000-00016PubMed
2.
Spiess BD, Ley C, Body SC, et al.: Haematocrit value on intensive care unit entry influences the frequency of Q-wave myocardial infarction after coronary artery bypass grafting. J Thorac Cardiovasc Surg 1998, 116: 460-467.CrossRefPubMed
Metadata
Title
An audit of blood and blood product use in the Cardiac Intensive Care Unit (CICU)
Authors
L Bell
L Anderson
A Macfie
Publication date
01-12-2000
Publisher
BioMed Central
Published in
Critical Care / Issue Special Issue 5/2000
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc708

Other articles of this Special Issue 5/2000

Critical Care 5/2000 Go to the issue

Meeting abstract

Acute normovolaemic haemodilution (ANH) is safe in patients with known coronary artery disease

Meeting abstract

Evaluation of a new real continuous cardiac output pulmonary artery catheter

Meeting abstract

High thoracic epidural and remifentanil for anaesthesia for cardiac surgery in morbidly obese patients with obese hypoventilation syndrome

Meeting abstract

S100β after coronary artery surgery: association with lipid peroxidation and neurocognitive scores

Meeting abstract

The effects of remifentanil on haemodynamic stability during rigid bronchoscopy